Dr. Guo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
49 NY-347
Port Jefferson Station, NY 11776
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
University of Texas M.D. Anderson Cancer CenterResidency, 2023
New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 2017 - 2020
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2017
Certifications & Licensure
NY State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 13 citationsMulti-Center Analysis of Practice Patterns and Outcomes of Younger and Older Patients with Mantle Cell Lymphoma in the Rituximab Era.Reem Karmali, Jeffrey M. Switchenko, Subir Goyal, Krithika Shanmugasundaram, Michael C. Churnetski
American Journal of Hematology. 2021-07-29 - 25 citationsEarly Relapse Identifies MCL patients with Inferior Survival after Intensive or Less Intensive Frontline Therapy.David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski
Blood Advances. 2021-09-13 - 3 citationsIntensive Induction Regimens after Deferring Initial Therapy for Mantle Cell Lymphoma Are Not Associated with Improved SurvivalKrithika Shanmugasundaram, Subir Goyal, J. Switchenko, Oscar Calzada, Michael C. Churnetski
European Journal of Haematology. 2021-05-11
Abstracts/Posters
- Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine + Rituximab without Autologous TransplantJin Guo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell LymphomaJin Guo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes Following Early Relapse in Patients with Mantle Cell LymphomaJin Guo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
New York Cancer & Blood Specialists Welcomes Jin Guo, MDSeptember 8th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
